Susceptibility as opposed to resistance of mouse strains (eg, BALB/c vs C57BL/6) to Leishmania major has been attributed to a defective Th1 and a predominant Th2-response, resulting in increased IL-4 and IgE production, and decreased interferon gamma (IFN␥) production, macrophage activation and elimination of parasites. Here we report dissection of genetic and functional aspects of susceptibility to leishmaniasis using two contrasting inbred strains BALB/cHeA (susceptible) and STS/A (resistant) and a resistant Recombinant Congenic (RC) Strain, CcS-5/Dem, which carries a random set of 12.5% of genes from the strain STS and 87.5% genes from the susceptible strain BALB/c. Linkage analysis of F 2 hybrids between the resistant RC strain CcS-5 and the susceptible strain BALB/c revealed five loci affecting the response to the infection, each apparently associated with a different combination of pathological symptoms and immunological reactions. The correlation between Th2-type immune reactions and the disease in the F 2 mice was either absent, or it was limited to mice with specific genotypes at loci on chromosomes 10 and 17. This suggests that the resistance vs susceptibility is influenced by mechanisms additional to the postulated antagonistic effects of Th1 and Th2 responses, and that the host's genotype affects the development of leishmaniasis in a complex way. Genes and Immunity (2000) 1, 200-206. 
Introduction
Leishmania major infects mononuclear phagocytes of vertebrate hosts. In most mouse strains this infection causes no or only transient pathological changes, whereas some strains develop systemic visceral disease with splenoand hepatomegaly, anemia, hypergammaglobulinemia and skin lesions. This non-healer phenotype has been shown to be associated with high levels of IL-4 and IgE production and low levels of interferon gamma (IFN␥) production 1,2 and low macrophage anti-parasite activation by antigen-stimulated CD4 T lymphocytes. 3 Similar symptoms were seen in patients with active leishmaniasis (reviewed in Philips 4 and the role of different T cell subsets. [5] [6] [7] However, these early stages are not accessible to analysis in patients presenting for therapy and the genetic control of the pathways leading from the early responses to the fully developed disease is not known. Therefore, the analysis of the early stages of immune response needs to be complemented by the study of the progression towards the fully developed disease. Moreover, the multigenic nature of the control of non-healer phenotype [8] [9] [10] suggests that different genetic factors contribute to susceptibility by different mechanisms. Therefore, genetic dissection of the L. major-induced immunopathology may help to elucidate the different components which contribute to the disease in individuals of different genotypes and possibly also to individualize the strategies for therapy. In this paper we present the mapping of genes controlling the pathological and immunological aspects of the L. majorinduced disease. To dissect the multigenic control of L. major susceptibility, we used Recombinant Congenic (RC) strains, a special tool for genetic analysis of multigenically controlled biological traits. 11 The 20 BALB/c-c-STS/Dem (CcS/Dem) RC strains were derived from two inbred strains, BALB/cHeA (BALB/c) and STS/A (STS), which are susceptible and resistant to L. major induced disease, respectively. 12 Each of the 20 CcS/Dem strains contains a different random set of about 12.5% genes from the 201 strain STS and 87.5% genes from the strain BALB/c. As a consequence, the individual STS genes contributing to the resistance were distributed among different CcS/Dem strains. In these tests the CcS-5/Dem (CcS-5) strain turned out to be highly resistant 8 in spite of its overall genetic similarity to BALB/c. We analyzed the genetic loci responsible for the high resistance of the CcS-5 strain or influencing various immunological parameters of the response to L. major.
Results

Strain differences
The pathological and immunological phenotypes associated with the infection in the three strains are given in Table 1 . In infected mice the skin lesions began to appear 3-4 weeks after infection. BALB/c mice were highly susceptible to skin lesions, but STS and most CcS-5 mice did not develop any ulcerative lesions. Similarly, whereas BALB/c mice showed high parasite load in spleens, no parasites were visible in spleens of STS and CcS-5 mice. The number of parasites in the lymph nodes was also smaller in STS and CcS-5 mice than in BALB/c, and L. major was recovered from cultures of spleen cells in 85% of BALB/c mice but only 25% of STS and CcS-5 mice. Parasites were detected in lymph nodes or spleens even in mice which recovered from the primary infection, similarly to findings of others. 13 Splenomegaly was significantly smaller in STS and CcS-5 mice than in BALB/c mice, hepatomegaly was pronounced in BALB/c, intermediate in CcS-5, and low in STS mice, whereas the relative spleen and liver weights did not differ between control mice of these strains. Eight weeks after infection the IgE, IL-4 and IFN␥ levels in serum were high in BALB/c but lower in STS and CcS-5, the IL-12 levels were higher in BALB/c and CcS-5 than in STS mice. There has been a significant correlation between the serum IL-4 levels and spleen IL-4 mRNA levels measured by RT-PCR (data not shown). These data indicate that although the strain CcS-5 received only about 12.5% of genes from STS, it resembles STS in most immunopathological parameters and differs significantly from BALB/c in spite of carrying about 87.5% of BALB/c genome. Hence, the strain CcS-5 is likely to contain one or more genes responsible for the resistant phenotype of STS. Its limited overall genetic difference from BALB/c can facilitate mapping of these genes.
Loci controlling L. major-induced disease and immune response (Leishmania major -response, Lmr) The F 2 hybrids between BALB/c × CcS-5 were genotyped with microsatellite markers covering the 12 STS derived segments on eight chromosomes [Stassen et al 14 and unpublished data]. Linkage analysis of different parameters of the disease indicated five novel loci (Table 2) :
Lmr3 (Leishmania major response 3) on chromosome 5 linked to D5Mit112. Its BALB/c allele is associated with splenomegaly, hepatomegaly and high serum IgE and IFN␥ (corr. P = 0.046, 0.052, 0.058 and 0.0092, respectively).
Two loci were found to control the skin lesions. Lmr4 (chromosome 6) is linked to D6Mit122. Its BALB/c allele is associated with larger lesions (corr. P = 0.017). Lmr5 (chromosome 10) is linked to D10Mit46, D10Mit14 and
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D10Mit25. Its BALB/c allele is associated with larger lesions and higher levels of IgE, IL-12, IFN␥ and likely also splenomegaly (corr. P = 0.00058, 0.0000016, 0.0085, 0.018 and 0.065 respectively). BALB/c alleles of Lmr4 and Lmr5 synergize in increasing the IFN␥ levels (corr. P = 0.011; Table 3 ).
Lmr6 near D11Mit62 (chromosome 11) influences IL-4 levels in serum (corr. P = 0.00083).
Lmr7 on chromosome 17 marked by D17Mit19 and D17Mit30 controls in vitro proliferation of spleen cells of infected mice (corr. P = 0.021). The high proliferation is associated with the STS allele.
Genotype influences the correlation between different aspects of pathology and immune response
In the F 2 hybrids between BALB/c and CcS-5, we found an influence of the genotype on the correlation between IL-4 and lesion size, IFN␥ and IgE levels in serum (Table  4 ). In the total population of 256 F 2 hybrids the correlations between these parameters were R = 0.3561, 0.3664, 0.4010, respectively, P Ͻ 0.00001 in all cases. However, when sorted by genotype, the IL-4 levels correlated with lesion size in homozygotes for the BALB/c allele of D10Mit46 but not in STS homozygotes (P = 0.0013). IL-4 and IFN␥ levels were correlated only in homozygotes for the BALB/c allele of D10Mit25 (P = 0.0018); IL-4 and IgE levels were correlated in homozygotes for the BALB/c but not for the STS allele of D17Mit19 (P = 0.0018).
Discussion
Immune response to parasites comprises components which minimize the parasite associated pathology as well as components contributing to pathological changes. 4 The complexity of the disease phenotype may obscure the causal connections between the various functional and pathological changes. Comparison of pathophysiology of susceptible and resistant strains might help to distinguish between the primary and the secondary features. However, the mechanistic interpretation of such studies may be difficult if the number of susceptibility genes involved is large. The RCS system reduces the genetic differences and hence provides more precise information about the relationship between different functional and pathological aspects of the disease. The resistant strain STS differs significantly from BALB/c in all parameters tested except IL-4 level in serum, and the CcS-5 strain resembles STS in most parameters (Table 1) showing that although it has 87.5% of its genes from BALB/c, it inherited from STS a subset of genes which strongly affect the development of disease.
We present the genetic dissection of resistance of the RC strain CcS-5. Several chromosomal regions of CcS-5 were mapped which contain one or more loci influencing various aspects of response to L. major infection. Significantly, the functional effect of each region is different (Tables 2, 3 and 5) . Lmr3 near D5Mit112 controls serum IFN␥ and IgE levels, splenomegaly and also hepatomegaly. Interestingly, Tir2 (trypanosome infection response 2) also maps to this region. 15 Lmr4 linked to D6Mit112 controls lesion size. Lmr5 near D10Mit25 controls lesion size, IgE, IL-12 and IFN␥ levels and also splenomegaly, but not hepatomegaly (Tables 2 and 5 ). Loci near D6Mit122 -D6Mit10 and D10Mit25 interact in determining IFN␥ level in serum. Lmr6 near D11Mit62 controls IL- 
10) 
The numbers give log 10 of spleen to body weight ratio × 1000, log 10 of liver to body weight ratio × 1000, the lesion size in mm 2 transformed to the power of 0.1, log 10 of IgE in serum (in ng/ml), ln of IL-4 level in serum (in ng/ml), IL-12 in serum (in ng/ml), log 10 of IFN␥ in serum (in ng/ml), [ 3 H]-thymidine incorporation (cpm) indicating growth of lymphocytes transformed to the power of 0.3. P-values were corrected for genome-wide scan. 37 C, BALB/c allele; S, STS allele. 11, and 17 there are no obvious candidate genes. On chromosomes 6 and 10 several genes are localized that were reported to influence the response to L. major (http: //www.informatics.jax.org/mgd.html) [16] [17] [18] [19] (Table 5 ). The role of these potential candidate genes is being tested by recombinant mapping. 20 We did not detect any effect of the postulated major susceptibility gene Scl1 on chromosome 11 12 nor of Irf1, which is also on this chromosome and has been suggested as a potential candidate, 21 as this part of the chromosome 11 in the CcS-5 strain is of BALB/c origin. Beebe et al 9 and Roberts et al 10 analyzed the genetics of susceptibility assayed by lesion development. The locus Lmr1 on chromosome 17 10 is located telometric to Lmr7 on chromosome 17 described here. The region carrying Lmr2 on chromosome 9
10 is of BALB/c origin in CcS-5 and hence cannot play a role in its resistance. Suggestive but nonsignificant linkages with lesion development were reported 9 to markers on chromosomes 6, 11, and 15. However, Lmr4 on chromosome 6 described here is in a different location from that suggested by Beebe et al. 9 In fact the region in which they detected a suggestive linkage is of BALB/c origin in CcS-5 and hence cannot be involved in our studies. The significant linkage observed in our data and which defines Lmr6 on chromosome 11 coincides with the region of suggestive linkage in. 9 No evidence for involvement of chromosome 15 has been observed here, as in CcS-5 it is of BALB/c origin.
IgE production is controlled by several factors. [21] [22] [23] [24] [25] We describe a linkage of serum IgE level to loci on chromosomes 10 and 5, near D10Mit25 and D5Mit112, respectively. A number of loci controlling IgE level have been described in humans (reviewed in Holgate 26 ) including the cytokine cluster on human chromosome 5. 27 In the CcS-5 × BALB/c cross the segment of mouse chromosome 11 homologous with this cluster does not play a role, because CcS-5 received it from BALB/c. Total serum IgE concentration in humans was mapped to 12q15-q24.1, in the region homologous with the part of mouse chromosome 10, 28 where we mapped the Lmr5 locus. Proliferation rate of cultured lymphocytes from noninfected BALB/c and CcS-5 mice did not differ, whereas after 8 weeks of infection proliferative response of CcS-5 lymphocytes was higher. We did not detect any effect of the locus Lmr7 on chromosome 17 on pathological parameters. However, its effect on pathology, as well as that of the Lmr6 gene, might be visible on a different genetic background as Beebe et al 9 studied differences between strains BALB/c and B10.D2. Lmr7 maps to the region influencing also the correlation between IL-4 and IgE levels (Table 4) and is possibly responsible for this effect. The region of chromosome 16 influencing commitment to IL-4 production by CD4 + cells 29 is identical in strains BALB/c and CcS-5, 14 and hence cannot be responsible for phenomena observed in this cross.
It needs to be pointed out, that although we detected several loci in the RC strain CcS-5 influencing the course and outcome of the L. major infection, these loci do not explain the total difference between the parental strains BALB/c and STS. Other RC strains, which do not carry the STS alleles at these loci, also differ in their susceptibility and immunopathology from BALB/c (unpublished data), indicating that they inherited additional Lmr loci from the STS strain.
Two additional observed phenomena deserve discussion. First is the heterogeneity of the immunopathological phenotypes observed in the F 2 hybrids. Clearly, there is not a single pattern of the immunological parameters which is characteristic for susceptibility or for resistance. The surprising finding is the effect of loci in chromosomes 10 and 17 (possibly Lmr5 and Lmr7) on correlation between levels of IL-4 on one hand, and lesion size, IFN␥ levels, or IgE levels on the other hand. This may be due to involvement of these loci in some steps modifying the cellular responses to regulatory signals.
The detection of several loci influencing the response to L. major infection in CcS-5 mice, each of them apparently affecting a different combination of immunological and pathological features ( Table 5 ), indicates that the specific pattern of expression of components of the immune response and its relation to the disease are genetically determined. It is therefore not surprising that different combinations of genotypes at these loci can result in different relationships between these components.
In conclusion, we described five loci affecting various aspects of response to L. major infection and show that leishmaniasis can exhibit a variety of genetically influenced combinations of immunopathologic features. The host's genotype affects the specific pathway by which the disease develops or is prevented. A corollary to our findings is that a treatment aimed at the disruption of the pathogenic pathway could be optimized by taking into account the genotype of the individual.
Materials and methods
Mice
Females of strains BALB/c, STS and CcS-5 were 8 to 26 weeks old at the time of infection. The CcS-5 strain was in the 28th generation of inbreeding. The parts of its genome inherited from the BALB/c or STS parents were defined. 14 F 2 hybrids between CcS-5 and BALB/c were produced at The Netherlands Cancer Institute in Amsterdam and shipped to Prague at two separate times. In one group of female hybrids the onset of the disease was delayed 4 weeks, however, the linkage relationships in this group were not different from those in the other group.
Parasites
Leishmania major LV 561 (MHOM/IL/67/LRCL 137 JER-ICHO II) was maintained in rump lesions of BALB/c females. Amastigotes were transformed to promastigotes using blood agar SNB-9.
30,31 10 7 promastigotes from 6 days old subculture 2 were inoculated in 50 l sterile saline s.c. into mouse rump.
Disease phenotype
The size of the primary lesions was measured weekly using a Vernier caliper gauge. The mice were killed 8 weeks after infection, the blood was collected and body, spleen and liver weights were recorded. Parasite load in Giemsa stained impression smears from spleen and lymph nodes was expressed as the mean amastigote number from 100 fields observed using a 10 × eyepiece and a 100 × oil immersion lens.
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Cultivation of parasites After 8 weeks of infection, pieces of spleen were transferred to 24-well multidish (Falcon, Oxford, UK) containing (SNB-9), 30, 31 and 80 g/ml gentamycin in the overlay. The cultures were evaluated microscopically for the presence of parasites after 3, 7, and 14 days. Cytokine and IgE levels IL-4, IL-12, IFN␥ and IgE levels in serum were determined using the primary and secondary monoclonal antibodies (IL-4: BVD41D11, BVD624G2; IL-12: Red-T and G297-298, C17.8; IFN␥: R46A2, XMG1.2; IgE: R3572, R3592) and standards from Pharmingen, San Diego, CA, USA (recombinant mIL-4, mIL-12 p70 heterodimer, mIFN␥ and IgE3). The ELISA was performed as recommended by Pharmingen. The IL-4, IL-12, IFN␥ and IgE levels were estimated using the curve fitter program KIM-E.
Lymphocyte proliferation
RT-PCR
Total cellular RNA was prepared from homogenized spleens by the guanidium CsCl method. 34 Reverse transcription (RT) was performed with Superscript-RT (GIBCO BRL) using 2 g total RNA in a 20 l reaction volume as recommended by GIBCO. Polymerase chain reactions were set up using 1/10th of this cDNA in a 50 l reaction mix containing 5 l 10 × PCR buffer, 1.5 mm MgCl 2 , 0.2 mm dNTPs, 2.5 u Taq polymerase (all biochemicals were from GIBCO BRL) and 1 m primers (Stratagene). Cycling condition for PCR amplification of IL-4 and actin were 94°C for 30 s, 60°C for 45 s, IL-4 72°C for 1 min followed by a final extension for 10 min. Amplification of actin and IL-4 involved 30 and 35 cycles, respectively.
Simple sequence length polymorphisms DNA was isolated from tails. 35 The STS derived segments of the CcS-5 strain in F 2 hybrids were typed by PCR 36 using the primers from Research Genetics (Huntsville, AL, USA) for the following loci: D5Mit112, D5Mit164, D6Mit173, D6Mit122, D6Mit10, D8Mit155, D8Mit17, D10Mit46, D10Mit14, D10Mit25, D11Mit62, D16Mit91, D17Mit19, D17Mit46, D17Mit30, D17Mit51, D17Mit138 and D18Mit19. The largest distance between two markers in the STS-derived chromosomal segments or from the nearest BALB/c derived marker was 15.7 cM.
Statistical analysis
The linkage in F 2 hybrids was evaluated by analysis of variance and the Newman-Keuls multiple comparison test (NCSS). Strain and age were fixed factors and individual experiments were considered as a random parameter. For linkage study, markers and interactions with P Ͻ 0.05 were combined in a single model. The results were confirmed by using a mixed model analysis of variance with marker, gender and set (individual shipment of mice) as fixed effects and experiment, nested within set, as random effect; interactions including experiment (within set) were also considered to be random. The Pvalues (␣ T ) were corrected for multiple comparisons according to Lander and Kruglyak 37 using the formula:
with G = 2 Morgan (the length of the segregating part of the genome: 12.5% of 16 M); C = 8 (number of chromosomes segregating in this cross); = 1.5 for F 2 hybrids; h(T) = the observed statistics (F ratio). The Spearman correlation coefficients were computed by the NCSS package.
